Press & News

We love what we do. A lot of other important folks love it too. See what they have to say about us.

Public Relations: Andrew Noble

Press Releases

October 26, 2022
New

Parse Biosciences Announces Cloud Analysis Platform to Simplify Single Cell Analysis

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a new cloud analysis solution to simplify the analysis of single cell RNA sequencing (scRNA-seq). The new cloud analysis platform will provide an accessible option for researchers to analyze scRNA-seq data without required bioinformatics experience. The new solution is a direct result of a co-development collaboration between Parse Biosciences and DNAnexus, the leading provider of cloud-based genomic and biomedical data access and companion analysis software. 
Read More
October 25, 2022

DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting

DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. The company will also be showcasing its GxP-compliant platform and new Nextflow pipeline language support capabilities in booth #2103.
Read More
October 21, 2022

DNAnexus Adds Jeff Margolis to Board of Directors

DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the appointment of Jeff Margolis, a seasoned healthcare information technology executive and current Senior Advisor for Blackstone (NYSE:BX), to its Board of Directors. The appointment follows the company’s $200 million financing round, which was led by Blackstone.
Read More
September 20, 2022

DNAnexus Appoints Chief Commercial Officer to Accelerate Global Adoption of Leading Biomedical Data-Driven Technology Platform

MOUNTAIN VIEW, Calif. — DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the appointment of Stephen Nuckols as Chief Commercial Officer. The appointment follows the company’s recent $200 million financing round, which was led by Blackstone. Nuckols will be responsible for building on the company’s success, driving its commercial growth strategy, and leading its sales, solution science, and marketing functions.
Read More
September 12, 2022

DNAnexus Selected as Platform Provider of the Trusted Research Environment for UK’s Largest Health Research Program

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that it has been awarded a three-year contract by Our Future Health. The DNAnexus platform, which will be hosted in the UK, will provide approved researchers with a scalable, cloud-based trusted research environment for accessing and analyzing Our Future Health’s growing biomedical dataset and tools to drive biological insights and global collaborations to advance precision medicine.
Read More

Video

Natera & DNAnexus: Scaling Genetic Testing Globally

Case Study New

TwinStrand Biosciences: Overcoming Bioinformacs Challenges to Rapidly Scale Genomics Pipelines

Dedicated to Detecting Ultra-Rare Variants with Unparalleled Sensitivity and Specificity
TwinStrand chose DNAnexus to provide the scalable and secure cloud infrastructure it needed to support customers of its DuplexSeq™ kits.

March 18, 2022
New

Blackstone Growth Leads $200 Million Investment in DNAnexus

One or two lines of text from article goes here mollis, mauris orci dignissim nisl, id gravida nunc enim quis nibh. Maecenas convallis eros a ante dignissim, vitae elementum metus facilisis. Cras in maximus sem. Praesent libero augue, ornare eget quam sed, volutpat suscipit arcu.
Read More
  • DNAnexus Solutions are used by......

  • 7 of the world’s top 10 pharmaceutical companies

  • 8 of the 10 biggest diagnostics developers

Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases.
James R. Downing, President & CEO
St. Judes Children’s Research Hospital